2018-2019 Influenza Season Week 11 ending March 16, 2019
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

Filetype[PDF-611.19 KB]



  • Details:

    • Description:
      All data are preliminary and may change as more reports are received.

      An overview of the CDC influenza surveillance system, including methodology and detailed descriptions of each data component, is available at http://www.cdc.gov/flu/weekly/overview.htm.

      Synopsis: Influenza activity remains elevated in the United States. Influenza A(H1N1)pdm09, influenza A(H3N2), and influenza B viruses continue to co-circulate. Below is a summary of the key influenza indicators for the week ending March 16, 2019:

      • Viral Surveillance: The percentage of respiratory specimens testing positive for influenza viruses in clinical laboratories increased slightly. Nationally, during the most recent three weeks, influenza A(H3) viruses were reported more frequently than influenza A(H1N1)pdm09 viruses and in HHS Regions 2, 4, 5, 6, 7, 8, 9 and 10.

      o Virus Characterization: The majority of influenza viruses characterized antigenically are similar to the cell-grown reference viruses representing the 2018–2019 Northern Hemisphere influenza vaccine viruses. However, an increasing proportion of influenza A(H3N2) viruses are antigenically distinguishable from A/Singapore/INFIMH-16-0019/2016 (3C.2a1), a cell-propagated reference virus representing the A(H3N2) component of 2018-19 Northern Hemisphere influenza vaccines.

      o Antiviral Resistance: The vast majority of influenza viruses tested (>99%) show susceptibility to oseltamivir and peramivir. All influenza viruses tested showed susceptibility to zanamivir.

      • Influenza-like Illness Surveillance: The proportion of outpatient visits for influenza-like illness (ILI) remained at 4.4%, which is above the national baseline of 2.2%. All 10 regions reported ILI at or above their region-specific baseline level.

      o ILI State Activity Indictor Map: 26 states experienced high ILI activity; 12 states experienced moderate ILI activity; New York City, Puerto Rico and eight states experienced low ILI activity; four states experienced minimal ILI activity; and the U.S. Virgin Islands and the District of Columbia had insufficient data.

      • Geographic Spread of Influenza: The geographic spread of influenza in 44 states was reported as widespread; Puerto Rico and four states reported regional activity; the District of Columbia and two states reported local activity; the U.S. Virgin Islands reported sporadic activity; and Guam did not report.

      • Influenza-associated Hospitalizations A cumulative rate of 47.1 laboratory-confirmed influenza-associated hospitalizations per 100,000 population was reported. The highest hospitalization rate is among adults 65 years and older (146.0 hospitalizations per 100,000 population).

      • Pneumonia and Influenza Mortality: The proportion of deaths attributed to pneumonia and influenza (P&I) was below the system-specific epidemic threshold in the National Center for Health Statistics (NCHS) Mortality Surveillance System.

      • Influenza-associated Pediatric Deaths: Eight influenza-associated pediatric deaths were reported to CDC during week 11.

    • Document Type:
    • Place as Subject:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov